Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

The Kaposi's sarcoma (KS)-associated herpesvirus is a lymphotropic virus strongly implicated in the pathogenesis of KS and several lymphoproliferative disorders. The KS-associated herpesvirus K1 gene encodes a transmembrane protein bearing a functional immunoreceptor tyrosine-based activation motif (ITAM)-like sequence; it previously has been proposed to be important in viral tumorigenesis because its expression can trigger cell proliferation in vitro and in vivo. Here we show that expression of the full-length K1 protein can initiate calcium-dependent signal transduction in B cells; however, unlike other ITAM-based signal transduction events, K1 signaling occurs constitutively, in the absence of exogenous crosslinking ligands. This property is caused by its cysteine-rich ectodomain, which when transferred to other consensus ITAMs induces constitutive signaling. Although ITAM-based signaling by K1 involves classical syk and phospholipase C gamma2 activation, both ITAM- and syk-independent signaling pathways are activated by K1 expression. These studies indicate that K1 is a deregulated signaling molecule with pleitropic effects that may explain its known growth deregulatory properties.

[1]  Jae U. Jung,et al.  Identification of an Immunoreceptor Tyrosine-Based Activation Motif of K1 Transforming Protein of Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Molecular and Cellular Biology.

[2]  Jeffrey N. Martin,et al.  Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.

[3]  R. Desrosiers,et al.  Deregulation of cell growth by the K1 gene of Karposi's sarcoma-associated herpesvirus , 1998, Nature Medicine.

[4]  D. Ganem,et al.  The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. , 1997, Virology.

[5]  A. DeFranco,et al.  The complexity of signaling pathways activated by the BCR. , 1997, Current opinion in immunology.

[6]  N. Isakov Immunoreceptor tyrosine‐based activation motif (ITAM), a unique module linking antigen and Fc receptors to their signaling cascades , 1997, Journal of leukocyte biology.

[7]  A. Haase,et al.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.

[8]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. A. Goldman,et al.  Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. , 1996, BioTechniques.

[10]  W. Greene,et al.  c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1 , 1996, The Journal of experimental medicine.

[11]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[12]  Wei Wei Wu,et al.  Induction of cell cycle regulatory proteins in anti-immunoglobulin- stimulated mature B lymphocytes , 1996, The Journal of experimental medicine.

[13]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[14]  J. Phair,et al.  Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. , 1996, The New England journal of medicine.

[15]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[16]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.

[17]  K. Sada,et al.  Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling , 1995, The Journal of experimental medicine.

[18]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[19]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[20]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[21]  E. Kieff,et al.  Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. , 1995, Immunity.

[22]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[23]  J. Schlessinger,et al.  The catalytic activity of the CD45 membrane‐proximal phosphatase domain is required for TCR signaling and regulation. , 1994, The EMBO journal.

[24]  A. Hata,et al.  Tyrosine kinases Lyn and Syk regulate B cell receptor‐coupled Ca2+ mobilization through distinct pathways. , 1994, The EMBO journal.

[25]  A. Weiss,et al.  Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. , 1994, Science.

[26]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[27]  D. Choquet,et al.  The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein‐Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. , 1993, The EMBO journal.

[28]  M. Reth,et al.  Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus , 1993, Current Biology.

[29]  E. Kieff,et al.  Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes , 1993, Journal of virology.

[30]  A. Weiss,et al.  Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain , 1993, The Journal of experimental medicine.

[31]  G. Crabtree,et al.  Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. , 1993, The Journal of biological chemistry.

[32]  A. Kazlauskas,et al.  The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. , 1992, Science.

[33]  R. Gallo,et al.  Cytokines and Growth Factors in the Pathogenesis of AIDS‐Associated Kaposi's Sarcoma , 1992, Immunological reviews.

[34]  A. Rao,et al.  Nuclear factor of activated T cells contains Fos and Jun , 1992, Nature.

[35]  J. Hutchcroft,et al.  B lymphocyte activation is accompanied by phosphorylation of a 72-kDa protein-tyrosine kinase. , 1991, The Journal of biological chemistry.

[36]  R. Desrosiers,et al.  Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Arthur Weiss,et al.  The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways , 1991, Cell.

[38]  B. Seed,et al.  Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides , 1991, Cell.

[39]  M. Reth Antigen receptor tail clue , 1989, Nature.

[40]  S. Nakamura,et al.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.

[41]  R. Desrosiers,et al.  Herpesvirus saimiri and Herpesvirus ateles , 1982 .